APIs for liver disease are a class of drugs mainly used to treat hepatitis, cirrhosis, and hepatic encephalopathy. Many liver diseases, especially viral hepatitis, currently have no specific drugs. Studies have found that many viral hepatitis, primary biliary cirrhosis, sclerosing cholangitis, etc., may be related to autoimmunity, and the onset of hepatic encephalopathy may be related to elevated blood ammonia or abnormal neurotransmitters in the brain. Therefore, the drugs used clinically to treat liver disease mainly include immunosuppressants and drugs that lower blood ammonia and correct central neurotransmitter disorders.

Protheragen-ING provides a full range of APIs for liver diseases to support the research of global customers.